American Healthcare REIT, Inc. has announced through a recent filing that Director Scott Estes intends to sell 2,500 shares of the company’s common stock. This transaction, reported in a Form 144 filed with the SEC on November 10, 2026, is valued at approximately $148,300. Such insider sales can often indicate confidence or shifts in strategy within the company, making it an important event for stakeholders.

Background

American Healthcare REIT, Inc. operates as a real estate investment trust (REIT) focused on healthcare-related properties. The company is listed on the New York Stock Exchange under the ticker symbol AHR. It is classified under the SIC code 6798, which encompasses Real Estate Investment Trusts. The company was previously known as Griffin-American Healthcare REIT IV, Inc. before its name change in December 2015.

What the Filing Says

The SEC filing indicates that Scott Estes acquired the shares through restricted stock vesting on June 25, 2026. The filing states, "The approximate sale date is 11/10/2026," and confirms that the shares are to be sold through Merrill, a brokerage firm.

Impact

This planned sale may affect investor sentiment regarding American Healthcare REIT, particularly among shareholders and potential investors. Insider transactions can often lead to speculation about the company's future performance and strategic direction. The sale of shares by a director may raise questions about the company's growth prospects or the director's confidence in the stock's future performance.

What's Next

The filing does not say what happens next regarding the sale or any potential future transactions by Scott Estes or other insiders.